Clinical Trials Directory

Trials / Completed

CompletedNCT01466348

Effects of a Common Cold Treatment on Cognitive Function

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
72 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A reduction in alertness and lower levels of performance are commonly associated with the common cold. Paracetamol has been shown to be more effective than placebo in treating symptoms associated with upper respiratory tract infection; caffeine has been shown to increase levels of alertness and improve performance of people suffering from colds. This study will investigate any improvement in alertness and performance based on cognitive function and mood assessment in subjects suffering from the common cold, when taking a novel paracetamol and caffeine combination verses paracetamol alone.

Conditions

Interventions

TypeNameDescription
DRUGParacetamol and CaffeineParacetamol 1000 mg and caffeine 130 mg
DRUGParacetamolParacetamol 1000 mg

Timeline

Start date
2011-02-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2011-11-07
Last updated
2013-11-25
Results posted
2013-11-25

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01466348. Inclusion in this directory is not an endorsement.